Navigation überspringen
Universitätsbibliothek Heidelberg
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Kirchner, Martina [VerfasserIn]   i
 Glade, Julia [VerfasserIn]   i
 Lehmann, Ulrich [VerfasserIn]   i
 Merkelbach-Bruse, Sabine [VerfasserIn]   i
 Hummel, Michael [VerfasserIn]   i
 Lehmann, Annika [VerfasserIn]   i
 Trautmann, Marcel [VerfasserIn]   i
 Kumbrink, Jörg [VerfasserIn]   i
 Jung, Andreas [VerfasserIn]   i
 Dietmaier, Wolfgang [VerfasserIn]   i
 Endris, Volker [VerfasserIn]   i
 Kazdal, Daniel [VerfasserIn]   i
 Plöger, Carolin [VerfasserIn]   i
 Evert, Matthias [VerfasserIn]   i
 Horst, David [VerfasserIn]   i
 Kreipe, Hans [VerfasserIn]   i
 Kirchner, Thomas [VerfasserIn]   i
 Wardelmann, Eva [VerfasserIn]   i
 Büttner, Reinhard [VerfasserIn]   i
 Weichert, Wilko [VerfasserIn]   i
 Dietel, Manfred [VerfasserIn]   i
 Schirmacher, Peter [VerfasserIn]   i
 Stenzinger, Albrecht [VerfasserIn]   i
 Pfarr, Nicole [VerfasserIn]   i
Titel:NTRK testing
Titelzusatz:First results of the QuiP-EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA-based NGS assays
Verf.angabe:Martina Kirchner, Julia Glade, Ulrich Lehmann, Sabine Merkelbach-Bruse, Michael Hummel, Annika Lehmann, Marcel Trautmann, Jörg Kumbrink, Andreas Jung, Wolfgang Dietmaier, Volker Endris, Daniel Kazdal, Carolin Ploeger, Matthias Evert, David Horst, Hans Kreipe, Thomas Kirchner, Eva Wardelmann, Reinhard Büttner, Wilko Weichert, Manfred Dietel, Peter Schirmacher, Albrecht Stenzinger, Nicole Pfarr
Jahr:2020
Umfang:9 S.
Fussnoten:First published: 22 April 2020 ; Gesehen am 05.01.2022
Titel Quelle:Enthalten in: Genes, chromosomes & cancer
Ort Quelle:New York, NY : Wiley-Liss, 1989
Jahr Quelle:2020
Band/Heft Quelle:59(2020), 8, Seite 445-453
ISSN Quelle:1098-2264
Abstract:Gene fusions involving the three neurotrophic tyrosine receptor kinase genes NTRK1, NTRK2, or NTRK3 were identified as oncogenic drivers in many cancer types. Two small molecule inhibitors have been tested in clinical trials recently and require the detection of a NTRK fusion gene prior to therapeutic application. Fluorescence in situ hybridization (FISH) and targeted next-generation sequencing (tNGS) assays are commonly used for diagnostic profiling of gene fusions. In the presented study we applied an external quality assessment (EQA) scheme in order to investigate the suitability of FISH and RNA-/DNA-based tNGS for detection of NTRK fusions in a multinational and multicentric ring trial. In total 27 participants registered for this study. Nine institutions took part in the FISH-based and 18 in the NGS-based round robin test, the latter additionally subdivided into low-input and high-input NGS methods (regarding nucleic acid input). Regardless of the testing method applied, all participants received tumor sections of 10 formalin-fixed and paraffin-embedded (FFPE) tissue blocks for in situ hybridization or RNA/DNA extraction, and the results were submitted via an online questionnaire. For FISH testing, eight of nine (88.8%) participants, and for NGS-based testing 15 of 18 (83.3%) participants accomplished the round robin test successfully. The overall high success rate demonstrates that FISH- and tNGS-based NTRK testing can be well established in a routine diagnostic setting. Complementing this dataset, we provide an updated in silico analysis on the coverage of more than 150 NTRK fusion variants by several commercially available RNA-based tNGS panels.
DOI:doi:10.1002/gcc.22853
URL:kostenfrei: Volltext ; Verlag: https://doi.org/10.1002/gcc.22853
 kostenfrei: Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/gcc.22853
 DOI: https://doi.org/10.1002/gcc.22853
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:FISH
 NGS
 NTRK
 NTRK fusion variants
 RNA sequencing
K10plus-PPN:1784831050
Verknüpfungen:→ Zeitschrift
 
 
Lokale URL UB: Zum Volltext

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68862909   QR-Code
zum Seitenanfang